Cite
HARVARD Citation
Berenguer‐Daizé, C. et al. (n.d.). OTX015 (MK‐8628), a novel BET inhibitor, displays in vitro and in vivo antitumor effects alone and in combination with conventional therapies in glioblastoma models. International journal of cancer. 139 (9), pp. 2047-2055. [Online].